GCP
EVH icon

Gill Capital Partners’s Evolent Health EVH Stock Holding History

Gill Capital Partners’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$89 Buy
+39
New +$124 ﹤0.01% 677

Other funds holding EVH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
RF
Rubicon Founders Nashville, Tennessee $138M AUM 61.96% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Gill Capital Partners's EVH Position: Q1 2026 in Review

Gill Capital Partners opened a new position in Evolent Health (EVH) in Q1 2026: 39 shares worth $89. The stake represents ﹤0.01% of the portfolio and ranks #677 among its holdings.

191 funds tracked by Wall St. Rank hold EVH as of Q1 2026.

  • Gill Capital Partners held 39 shares of Evolent Health worth $89 as of Q1 2026.
  • Evolent Health was a new Gill Capital Partners position in Q1 2026.
  • Evolent Health made up ﹤0.01% of Gill Capital Partners's portfolio in Q1 2026, its #677 holding.
  • 191 funds tracked by Wall St. Rank held Evolent Health as of Q1 2026.

Based on Gill Capital Partners's 13F filing for Q1 2026, filed 13 Apr 2026.